Whitehawk Therapeutics Stock (NASDAQ:WHWK)
Previous Close
$4.23
52W Range
$1.39 - $4.48
50D Avg
$3.44
200D Avg
$2.49
Market Cap
$193.98M
Avg Vol (3M)
$176.75K
Beta
0.62
Div Yield
-
WHWK Company Profile
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.